ReviewDiscover oncology2026

SMARCA4-deficient non-small cell lung cancer and immunotherapy resistance: mechanisms and novel strategies-a mini-review.

Xiaoluan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.